Open access · CC-BY
via OpenAlex
Advancing Geroscience Research – A Scoping Review of Regulatory Environments for Gerotherapeutics
John Muscedere, Carrie Shorey, Gustavo Duque, Perry Kim, Amanda L. Lorbergs, Chris McGlory, Reshma Aziz Merchant, John C. Newman, Yves Rolland, Bruno J. Vellas
The journal of nutrition health & aging · 2025 · ▲ 16 citations
Abstract
BACKGROUND: Globally, older adults are living longer but often in poorer health with multiple chronic conditions straining healthcare systems. Gerotherapeutics, which target the biological mechanisms of aging, could reduce this burden by extending healthspan(definition). However, before therapies can be adopted, they must undergo rigorous study and regulatory approval; existing regulatory frameworks and the barriers to their development are unknown. OBJECTIVE: We conducted a scoping review of geroscience regulatory frameworks and identified barriers to their development. METHODS: A comprehensive government, academic, and grey literature search in the United States, Europe, Canada, and other regions including Medline and EMBASE (via OVID), Google Scholar, CINAHL, and CADTH Grey Matters was conducted. For inclusion of only recent literature, searches were limited to English-language publications from 2014 to 2024. RESULTS: In 3,780 publications screened for inclusion, no regulatory frameworks for gerotherapeutics were found. In the 34 included publications, 4 major barriers were identified: 1) lack of recognition of the biological processes of aging as targets for medical intervention; 2) absence of clear regulatory pathways to evaluate aging-focused therapies; 3) economic uncertainties, including high development costs and limited incentives due to unclear regulatory environments; and 4) insufficient public and policy engagement. CONCLUSION: We did not identify any geroscience specific regulatory frameworks but identified barriers to their development. For biological aging to advance as a therapeutic target, stakeholders must develop comprehensive regulatory guidelines, incentivize research and conduct public education. Global collaboration is crucial to harmonize regulatory efforts and ensure equitable adoption of therapies, ultimately enhancing healthspan worldwide.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.jnha.2025.100637
- Canonical
- link ↗
- Fetched
- 2026-11-13 MST
Cite this
APA
Muscedere, J., Shorey, C., Duque, G., Kim, P., Lorbergs, A.L., McGlory, C., Merchant, R.A., Newman, J.C., Rolland, Y., & Vellas, B.J. (2025). Advancing Geroscience Research – A Scoping Review of Regulatory Environments for Gerotherapeutics. <em>The journal of nutrition health & aging</em>. https://doi.org/10.1016/j.jnha.2025.100637
Vancouver
Muscedere J, Shorey C, Duque G, Kim P, Lorbergs AL, McGlory C, et al. Advancing Geroscience Research – A Scoping Review of Regulatory Environments for Gerotherapeutics. The journal of nutrition health & aging. 2025. doi:10.1016/j.jnha.2025.100637.
BibTeX
@article{john2025Advanc,
title = {Advancing Geroscience Research – A Scoping Review of Regulatory Environments for Gerotherapeutics},
author = {John Muscedere and Carrie Shorey and Gustavo Duque and Perry Kim and Amanda L. Lorbergs and Chris McGlory and Reshma Aziz Merchant and John C. Newman and Yves Rolland and Bruno J. Vellas},
journal = {The journal of nutrition health & aging},
year = {2025},
doi = {10.1016/j.jnha.2025.100637},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
The journal of nutrition, health & aging 2025
Open access · OA
Advancing Geroscience Research - A Scoping Review of Regulatory Environments for Gerotherapeutics.
Biomedical Reports 2025
Open access · CC-BY
Age reprogramming: Innovations and ethical considerations for prolonged longevity (Review)
iScience 2026
Open access · OA
Single-nucleus transcriptomics uncovers region-specific molecular features underlying selective aging vulnerability of cholinergic neurons
International Journal of Molecular Sciences 2020
Open access · CC-BY
The Role of Sirtuins in Kidney Diseases
Frontiers in pharmacology 2025
Open access · OA
Epigenetic pharmacology in aging: from mechanisms to therapies for age-related disorders.
Stem Cell Investigation 2017
Open access · CC-BY